Close
The page header's logo
Login
WHO Login
0
Selected 
Invert selection
Deselect all
Deselect all
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
play button
Conceptually Similar Documents
21867.jpg
purpose color
Syria receives first batch of COVID-19 vaccines through COVAX Facility 
04/21/2022 13:45:00 
21870.jpg
purpose color
Syria receives first batch of COVID-19 vaccines through COVAX Facility 
04/21/2022 13:38:00 
21871.jpg
purpose color
Syria receives first batch of COVID-19 vaccines through COVAX Facility 
04/21/2021 00:00:00 
21864.jpg
purpose color
Syria receives first batch of COVID-19 vaccines through COVAX Facility 
04/21/2021 00:00:00 
21875.jpg
purpose color
Syria receives first batch of COVID-19 vaccines through COVAX Facility 
04/21/2021 00:00:00 
21872.jpg
purpose color
Syria receives first batch of COVID-19 vaccines through COVAX Facility 
04/21/2021 00:00:00 
21866.jpg
purpose color
Syria receives first batch of COVID-19 vaccines through COVAX Facility 
04/21/2021 00:00:00 
23044.jpg
purpose color
Syria receives its first delivery of COVID-19 vaccines through the COVAX Facility - April 2021 
04/22/2021 10:01:00 
23054.jpg
purpose color
Syria receives its first delivery of COVID-19 vaccines through the COVAX Facility - April 2021 
04/22/2021 10:09:00 
23046.jpg
purpose color
Syria receives its first delivery of COVID-19 vaccines through the COVAX Facility - April 2021 
04/22/2021 09:57:00 
11125.jpg
purpose color
Islamic Republic of Iran receives second delivery of COVID-19 vaccines via COVAX 
05/16/2021 22:57:00 
11122.jpg
purpose color
Islamic Republic of Iran receives second delivery of COVID-19 vaccines via COVAX 
05/16/2021 22:57:00 
11096.jpg
purpose color
Egypt receives second delivery of COVID-19 vaccines via COVAX 
05/13/2021 00:00:00 
11095.jpg
purpose color
Egypt receives second delivery of COVID-19 vaccines via COVAX 
05/13/2021 00:00:00 
10701.jpg
purpose color
COVID-19 vaccines arrive in Iran via COVAX 
04/06/2021 00:00:00 
11099.jpg
purpose color
Egypt receives second delivery of COVID-19 vaccines via COVAX 
05/13/2021 00:00:00 
11098.jpg
purpose color
Egypt receives second delivery of COVID-19 vaccines via COVAX 
05/13/2021 00:00:00 
10680.jpg
purpose color
COVID-19 vaccines arrive in Iran via COVAX 
04/06/2021 00:00:00 
10677.jpg
purpose color
COVID-19 vaccines arrive in Iran via COVAX 
04/06/2021 00:00:00 
11139.jpg
purpose color
Islamic Republic of Iran receives second delivery of COVID-19 vaccines via COVAX 
05/16/2021 22:57:00 
Action button
Similar tones
similar-image
similar-image
similar-image
similar-image
similar-image
similar-image
similar-image
similar-image
similar-image
View images with similar tones
Action button
 Get link
 Copy Unique ID
Restrictions
If you want to request more than one asset, you can enter all Reference IDs in a single permission request form. 
 Download request for external user
Reference ID U27AN6A 
Headline Syria receives first batch of COVID-19 vaccines through COVAX Facility 
Description 203 000 doses of the Astra Zeneca vaccine from the Serum Institute of India arrived in Damascus through the COVAX Facility. This first batch of the vaccines will be allocated to frontline health workers, including health workers in northeast Syria. Simultaneously, a separate batch of 53 800 doses of Astra Zeneca vaccines for the high-risk populations in northwest Syria is also shipped through WHO and UNICEF offices in Gaziantep.Under the COVAX Facility, Syria is one of the 92 countries eligible for advance market distribution of COVID-19 vaccines. In coordination with GAVI - the Vaccine Alliance, WHO and UNICEF are providing detailed technical support to the national health authority in Syria to launch the national vaccination campaign later this month. 
Asset date 04/21/2022 
Country, area, WHO office Syrian Arab Republic
City Damascus 
State/Province Damascus 
WHO Region EMRO
Copyright © WHO 
Consent No 
File size 18.33 MB 
Visibility class: 
purpose color
Public 
Administered By EMRO Communications
Usage & views counts Usage (0) Views (30)